Centessa Pharmaceuticals plc (NASDAQ: CNTA) reported Q2 EPS of ($0.26), $0.22 better than the analyst estimate of ($0.48).

For earnings history and earnings-related data on Centessa Pharmaceuticals plc (CNTA) click here.